BCL2L1 and leukemia: For this purpose we first selected ABT-737, a BH3 mimetic, shown to inhibit the pro-survival function of Bcl-2, Bcl-xL and Bcl-w and to induce apoptosis in a variety of cancer cell types including leukemias [20], [21], [22].